Prostate-specific antigen, digital rectal examination and transrectal ultrasonography: A meta-analysis for this diagnostic triad of prostate cancer in symptomatic Korean men

Yonsei Medical Journal

Volumn 46, Issue 3, 2005, Pages 414-424

  Song, Jae Mann ^a   Kim, Chun Bae ^a,b   Chung, Hyun Chul ^a   Kane, Robert L ^b  

^a Yonsei University Wonju College of Medicine   (South Korea)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Digital rectal examination; Meta analysis; Prostate cancer; Prostate specific antigen; Transrectal ultrasonography

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ANTIGEN DETECTION; ARTICLE; CANCER DIAGNOSIS; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; HUMAN; INFORMATION PROCESSING; INTERMETHOD COMPARISON; KOREA; MALE; META ANALYSIS; PROSTATE BIOPSY; PROSTATE CANCER; QUALITY CONTROL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TRANSRECTAL ULTRASONOGRAPHY;

EID: 21844473992     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2005.46.3.414     Document Type: Article

References (56)

1. Troyer DA, Mubiru J, Leach RJ, Naylor SL. Promise and challenge: Markers of prostate cancer detection, diagnosis and prognosis. Dis Markers 2004;20:117-28.
2. Kataja VV. ESMO Guidelines Task Force. ESMO Minimum clinical recommendations for diagnosis, treatment and follow-up of prostate cancer. Ann Oncol 2003;14: 1010-1.
3. Cheon J, Kim CS, Lee ES, Hong SJ, Cho YH, Shin EC, et al. Survey of incidence of urological cancer in South Korea: A 15-year summary. Int J Urol 2002;9:445-54.
4. Whittemore AS, Kolonel LN, Wu AH, John EM, Gallagher RP, Howe GR, et al. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 1995;87:652-61.
5. Kolonel LN, Nomura AM, Cooney RV. Dietary fat and prostate cancer: Current status. J Natl Cancer Inst 1999; 91:414-28.
6. Mettlin C, Jones GW, Murphy GP. Trends in prostate cancer care in the United States, 1974-1990: Observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer. CA Cancer J Clin 1993;43:83-91.
7. Engelbrecht MR, Jager GJ, Laheij RJ, Verbeek AL, van Lier HJ, Barentsz JO. Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 2002;12:2294-302.
8. Cazares LH, Adam BL, Ward MD, Nasim S, Schellhammer PF, Semmes OJ, et al. Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry. Clin Cancer Res 2002;8:2541-52.
9. Best CJ, Leiva IM, Chuaqui RF, Gillespie JW, Duray PH, Murgai M, et al. Molecular differentiation of high-and moderate-grade human prostate cancer by cDNA microarray analysis. Diagn Mol Pathol 2003;12:63-70.
10. Hernandez J, Thompson IM. Prostate-specific antigen: A review of the validation of the most commonly used cancer biomarker. Cancer 2004;101:894-904.
11. Ablin RJ, Bronson P, Soanes WA, Witebsky E. Tissue-and species-specific antigens of normal human prostatic tissue. J Immunol 1970;104:1329-39.
12. Wang MC, Valenzuela LA, Murphy GP, Chu TM. Purification of a human prostate specific antigen. Invest Urol 1979;17:159-63.
13. Kang JH, Kim CI, Lee SJ. Clinical usefulness of prostatic acid phosphatase in prostate cancer: A comparative study with prostate specific antigen. Korean J Inf Dis 1982;38:1183-9.
14. Watanabe H, Igari D, Tanahashi Y, Harada K, Saitoh M. Transrectal ultrasonography of the prostate. J Urol 1975;114:734-9.
15. Kim ND, Kwon SW. Suprapubic ultrasonographic findings of the prostatic diseases. Korean J Urol 1982; 23:479-86.
16. Aziz DC, Barathur RB. Prostate-specific antigen and prostate volume: A meta-analysis of prostate cancer screening criteria. J Clin Lab Anal 1993;7:283-92.
17. Muris JW, Starmans R, Wolfs GG, Pop P, Knottnerus JA. The diagnostic value of rectal examination. Fam. Pract 1993;1034-7.
18. Haid M, Rabin D, King KM, Feistein CM, Janson KL, Levine SR, et al. Digital rectal examination, serum prostate specific antigen, and prostatic ultrasound: How effective is this diagnostic triad? J Sur Onc 1994; 56:32-8.
19. Hoogendam A, Buntinx F, de Vet HC. The diagnostic value of digital rectal examination in primary care screening for prostate cancer: A meta-analysis. Fam Pract 1999;16:621-6.
20. Hoffman RM, Clanon DL, Littenberg B, Frank JJ, Peirce JC. Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels. J Gen Intern Med 2000;15:739-48.
21. Bunting PS. Screening for prostate cancer with prostate-specific antigen: beware the biases. Clin Chim Acta 2002;315:71-97.
22. Mistry K, Cable G. Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma. J Am Board Fam Pract 2003;16:95-101.
23. Hasselblad V, Hedges L. Meta-analysis of screening and diagnostic tests. Psychol Bull 1995;117:167-77.
24. Hasselblad V, McCrory DC. Meta-analytic tools for medical decision making: A practical guide. Med Decis Making 1995;15:81-96.
25. Song HH. Meta-analysis in medicine, nurse, and social science research. 1st ed. Seoul: Chungmoonkak Press; 1998.
26. Kang SG. The evaluation of prostate cancer: TRUS (transrectal ultrasonography of prostate), DRE (digital rectal examination), serum PSA (prostate specific antigen). [Thesis of Master Degree]. Daejeon: Graduate School, Chungnam. National Univ.: 1991.
27. Kim TH, Lee JG, Cho JH. Predictability of PSA, DRE and TRUS for detection of prostatic cancer in considering the non-surgical treatment of BPH patients. Korean J Urol 1994;35:736-42.
28. Park HK, Ahn HJ. Role of prostate specific antigen, digital rectal examination and transrectal ultrasound in the diagnosis of prostate cancer. Korean J Urol 1994;35: 27-32.
29. Byun HS. Comparative evaluation of diagnostic values of digital rectal examination, serum PSA level and transrectal ultrasonography. [Thesis of Master Degree]. Seoul: Graduate School of Korea Univ.: 1995.
30. Park SW, Oh KH. Early experience of transperineal prostatic biopsy under transrectal ultrasound guidance. Korean J Urol 1995;36:1076-84.
31. Choi JH, Park HJ, Kwon CH. Clinical value of prostatic biopsy in patients with elevated serum PSA. Korean J Urol 1996;37:1110-6.
32. Seo WK, Kim GH, Park CH, Lee SC. Prostate cancer detection in clinical urologic practice: Comparison of digital rectal examination, serum PSA level, and transrectal ultrasonography. Korean J Urol 1996;37:150-5.
33. Kim JH, Park HJ, Kwon CH. Detection of prostate cancer by digital rectal examination, serum PSA and transrectal ultrasonography. Korean J Urol 1998;39:472-5.
34. Jung JY, Cho KS, Byeon SS, Kim KM, Paick JS, Lee SE. The value of prostate specific antigen density in the diagnosis of prostate adenocarcinoma. Korean J Urol 1998;39:355-60.
35. Yoon JH, Kim BH, Choi SH, Kim SH, Choi HY, Chai SE, et al. Usefulness of transrectal ultrasound in diagnosing prostate cancer: Comparison with digital rectal examination, prostate-specific antigen and prostate-specific antigen density. J Korean Radiol Soc 1998; 39:965-70.
36. Chang HJ, Sohn HG, Ha DB, Lee KS. Diagnostic value for early detection of prostate cancer of the digital rectal examination, serum prostate specific antigen and transrectal ultrasonography. Korean J Androl 1999;17: 39-43.
37. Kim JH, Chang SG, Kim YW. Pathologic diagnosis and clinical findings in patients undergoing transrectal prostatic biopsy. Korean J Urol 2000;41:492-9.
38. Jung BC, Kim TH, Jeong SJ, Kwak C, Lee SE. The clinical usefulness of the prostate-specific antigen, prostate-specific antigen density, digital rectal examination, and transrectal ultrasonography in the screening test of prostate cancer in Koreans. Korean J Urol 2002; 43:14-8.
39. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: Data-analytic approaches and some additional consideration. Stat Med 1993;12:1293-316.
40. Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA 1995;273:548-52.
41. Kim CB. Clinical practice guidelines in Korea: Development and implementation. QA 2001;8:108-33.
42. Irwig L, Macaskill P, Glasziou P, Fahey M. Meta-analytic methods for diagnostic test accuracy. J Clin Epidemiol 1995;48:119-30.
43. Lijmer JG, Bossuyt PM, Heisterkamp SH. Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat Med 2002;21:1525-37.
44. Cochrane Methods Working Group on Screening and Diagnostic Tests. Recommended methods. http://www.cochrane.org/cochrane/sadtdoc1.htm, 1996.
45. National Health and Medical Research Council. How to review the evidence: Systemic identification and review of the scientific literature. National Health and Medical Research Council, Canberra. 2000.
46. Hwang KH, Chung MK. Screening for prostatic cancers in Korean. Korean J Urol 1995;36:1062-70.
47. Yoon JH, Jung SI, Kim SI, Choi MS, Lee SH, Jung GW. Estimation of prostatic cancer prevalence in Korea: An epidemiological survey in Kangseo-Gu, Pusan. Korean J Urol 1998;39:994-1000.
48. Egger M, Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
49. Gerber GS, Thompson IM, Thisted R, Chodak GW. Disease-specific survival following routine prostate cancer screening by digital rectal examination. JAMA 1993;269:61-4.
50. Rifkin MD, Zerhouni EA, Gatsonis CA, Quint LE, Paushter DM, Epstein JI, et al. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer: Results of a multi-institutional cooperative trial. N Eng J Med 1990;323:621-6.
51. American College of Preventive Medicine (ACPM). Screening for prostate cancer in American men. Am J Prev Med 1998;15:81-4.
52. American Urological Association (AUA). Prostatic-specific antigen (PSA) best practice policy. Oncology (Huntingt) 2000;14:267-72, 277-8, 280
53. Singapore Ministry of Health (MOH). Prostate Cancer. Singapore: Ministry of Health (Singapore); 2000:49. (Ministry of Health Singapore clinical practice guidelines; no. 3/100).
54. Smith RA, von Eschenbach AC, Wender R, Levin B, Byers T, Rothenberger D, et al. ACS Prostate Cancer Advisory Committee, ACS Colorectal Cancer Advisory Committee, ACS Endometrial Cancer Advisory Committee. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001-testing for early lung cancer detection. CA Cancer J Clin 2001;51:38-75.
55. U.S. Preventive Services Task Force (USPSTF). Screening for prostate cancer: recommendations and rationale. Ann Intern Med 2002;137:915-6.
56. National Guideline Clearinghouse (NGC). Guideline synthesis: Screening for prostate cancer. http://www.guideline.gov/Compare/comparison.aspx?file=proscreen6.inc. 1998 (updated 2004).